Publication | Closed Access

A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer

Platelet CountsThrombosisThrombopoiesisPopulation Pharmacokinetic/pharmacodynamic ModelOncologyBreast OncologyBlood PlateletMedicineImmunologyBreast CancerPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyTumor MicroenvironmentTrastuzumab Emtansine